Innovation at IGTP
The Can Ruti Campus is a multidisciplinary space, where several biomedical institutions that produce leading scientific research at both national and international level are located. The synergies they produce have created a unique ecosystem for the development of innovation projects.
On campus the different institutions promote translational medicine and professionals carry out research, foster innovative ideas and generate knowledge designed to meet unmet clinical needs. This atmosphere has led the Innovation Unit of the Germans Trias i Pujol Research Institute to create a technology transfer model based on:
- Promotion of a culture of innovation among researchers that encourages motivating work environments, favors the generation of ideas, creativity, collaborations between professionals and an entrepreneurial vocation.
- The provision of a program to support projects with transfer potential, which allows their valorization and facilitates their transfer and an economic return for the Institute.
- The promotion of an open innovation model that complements the skills and technologies developed at the IGTP and establishes collaborations with other centers, companies and service providers
- Consolidation of the leadership of the Institute in research and innovation and promotion of its international projection.
The annual indicators of the Institute show the growth of innovative proposals in recent years, proposals that are meeting some of the great challenges of R+D+i. With 8 spin-offs, more than 160 active patents and approximately 30 licensing agreements, we are positioned as a center of reference and excellence in innovation in health.
The innovation model we use at the IGTP aims to catalyze and energize the projects that need to be commercialized. Through our program we support researchers in matters of validation of opportunities, funding, intellectual protection or transfer strategy.
As of April 2023, we have become an EATRIS Expert Centre, enabling us to provide services related to innovation management and health technology assessment through this network.
Innovation at IGTP in figures
-
22Incubated projects
-
7Technology offer portfolio
-
169Active patents
-
40Patent families
-
23License agreements
-
8Active spin-offs
Strategic alliances
Latest innovation news
IGTP and DevsHealth join forces to develop new antibiotics against hospital-acquired infections by multi-resistant Staphylococcus aureus
DevsHealth, a leading company in artificial intelligence (AI) driven drug discovery, and the Germans Trias i Pujol Research Institute (IGTP), a public research centre in biomedical sciences, have announced a new partnership to develop new antibiotics for multi-resistant Staphylococcus aureus infections.
Innomed Awards drive biomedical innovation
The Innomed Awards, held at the Can Ruti Campus, celebrated significant advancements in biomedical innovation and reinforced the commitment to collaboration among the leading healthcare and research institutions of this health ecosystem and its surroundings.